What Are Treatments for Uveitis? Uveitis is the inflammation of your uvea — the middle layer of your eye. It can happen for many reasons, but up to 70% of cases have unknown causes. It can affect a ...

Uveitis is inflammation of the middle layer of the eye, or the uvea, and the surrounding tissue. It can cause pain, eye redness, and cloudy vision. The term “uveitis” refers to a range of conditions ...

Iritis, also called anterior uveitis, is inflammation of the colored part of your eye called the iris. It can also cause inflammation in the space between your iris and the outer layer of your eye ...

After having surgery for uveitis-associated cataracts, patients who had experienced more uveitis attacks required longer ...

Significantly fewer patients in the fluocinolone acetonide intravitreal implant group experienced recurrence of uveitis at 6 months compared with the sham group. The Food and Drug Administration (FDA) ...

Uveitis can lead to serious eye problems if you don’t treat it right away. If you’ve had it for a long time, or if you have it and are over 60, your chance of having those problems goes up. The ...

Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown, shared human ...

Uveitis is a swelling of the middle layer of the eye, called the uvea. Treatments typically include steroid eye drops, oral steroids, and/or antibiotics. Uveitis may occur from both infectious and non ...

Are you searching for effective medications to treat 'Uveitis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for 'managing and ...

Researchers sought to better understand the risk for recurrence and precipitants for relapse in anterior uveitis, potentially allowing clinicians to better provide a prognosis and disease course with ...

Patients with thyroid disease have increased risk for uveitis, suggesting the two diseases may share a common autoimmune pathophysiology, researchers found. Compared with the general population, ...